Cargando…

A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro

BACKGROUND: Alzheimer’s disease (AD), the most common form of dementia, is a progressive neurodegenerative disorder that mainly affects older adults. One of the pathological hallmarks of AD is abnormally aggregated Tau protein that forms fibrillar deposits in the brain. In AD, Tau pathology correlat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aillaud, Isabelle, Kaniyappan, Senthilvelrajan, Chandupatla, Ram Reddy, Ramirez, Lisa Marie, Alkhashrom, Sewar, Eichler, Jutta, Horn, Anselm H. C., Zweckstetter, Markus, Mandelkow, Eckhard, Sticht, Heinrich, Funke, Susanne Aileen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783508/ https://www.ncbi.nlm.nih.gov/pubmed/35063014 http://dx.doi.org/10.1186/s13195-022-00959-z

Ejemplares similares

Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display
por: Malhis, Marwa, et al.
Publicado: (2021)

Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018)

Novel antibody against low‐n oligomers of tau protein promotes clearance of tau in cells via lysosomes
por: Chandupatla, Ram Reddy, et al.
Publicado: (2020)

FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
por: Kaniyappan, Senthilvelrajan, et al.
Publicado: (2020)

The release and trans-synaptic transmission of Tau via exosomes
por: Wang, Yipeng, et al.
Publicado: (2017)

Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity
por: Kumar, Satish, et al.
Publicado: (2014)

Spreading of Tau Protein Does Not Depend on Aggregation Propensity
por: Rodrigues, Sara, et al.
Publicado: (2023)

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
por: Aillaud, Isabelle, et al.
Publicado: (2022)

Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
por: Dammers, Christina, et al.
Publicado: (2016)

A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications
por: Drepper, Friedel, et al.
Publicado: (2021)

Reversal of Tau-Dependent Cognitive Decay by Blocking Adenosine A1 Receptors: Comparison of Transgenic Mouse Models with Different Levels of Tauopathy
por: Anglada-Huguet, Marta, et al.
Publicado: (2023)

Disease‐Associated Tau Phosphorylation Hinders Tubulin Assembly within Tau Condensates
por: Savastano, Adriana, et al.
Publicado: (2020)

Anti-aggregant tau mutant promotes neurogenesis
por: Joseph, Maria, et al.
Publicado: (2017)

Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice
por: Anglada‐Huguet, Marta, et al.
Publicado: (2021)

Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo
por: Gorsky, Marianna Karina, et al.
Publicado: (2016)

Molecular crowding and RNA synergize to promote phase separation, microtubule interaction, and seeding of Tau condensates
por: Hochmair, Janine, et al.
Publicado: (2022)

Liquid–liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau
por: Ambadipudi, Susmitha, et al.
Publicado: (2017)

Solid-state NMR investigation of the involvement of the P2 region in tau amyloid fibrils
por: Savastano, Adriana, et al.
Publicado: (2020)

Zn(2+) Aggravates Tau Aggregation and Neurotoxicity
por: Li, Xuexia, et al.
Publicado: (2019)

Residue-specific identification of phase separation hot spots of Alzheimer's-related protein tau
por: Ambadipudi, Susmitha, et al.
Publicado: (2019)

Properties of Oligomeric Interaction of the Cytomegalovirus Core Nuclear Egress Complex (NEC) and Its Sensitivity to an NEC Inhibitory Small Molecule
por: Kicuntod, Jintawee, et al.
Publicado: (2021)

Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies
por: Pickhardt, Marcus, et al.
Publicado: (2015)

Multivalent cross-linking of actin filaments and microtubules through the microtubule-associated protein Tau
por: Cabrales Fontela, Yunior, et al.
Publicado: (2017)

Structural Polymorphism of 441-Residue Tau at Single Residue Resolution
por: Mukrasch, Marco D, et al.
Publicado: (2009)

Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca(++) dysregulation
por: Decker, Jochen Martin, et al.
Publicado: (2015)

A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
por: Shammas, Sarah L., et al.
Publicado: (2015)

Tau protein liquid–liquid phase separation can initiate tau aggregation
por: Wegmann, Susanne, et al.
Publicado: (2018)

A PROSS-designed extensively mutated estrogen receptor α variant displays enhanced thermal stability while retaining native allosteric regulation and structure
por: Kriegel, Mark, et al.
Publicado: (2021)

Tau Oligomers Neurotoxicity
por: Niewiadomska, Grazyna, et al.
Publicado: (2021)

Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology
por: Michel, Claire H., et al.
Publicado: (2014)

Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model
por: Pir, Ghulam Jeelani, et al.
Publicado: (2016)

Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
por: Hochgräfe, Katja, et al.
Publicado: (2015)

Nuclear Egress Complexes of HCMV and Other Herpesviruses: Solving the Puzzle of Sequence Coevolution, Conserved Structures and Subfamily-Spanning Binding Properties
por: Marschall, Manfred, et al.
Publicado: (2020)

Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein
por: Timm, Thomas, et al.
Publicado: (2008)

Oligomer Formation of Tau Protein Hyperphosphorylated in Cells
por: Tepper, Katharina, et al.
Publicado: (2014)

A Peptide Inhibitor of the Human Cytomegalovirus Core Nuclear Egress Complex
por: Alkhashrom, Sewar, et al.
Publicado: (2022)

The Neurotoxic Role of Extracellular Tau Protein
por: Sebastián-Serrano, Álvaro, et al.
Publicado: (2018)

Self‐Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
por: Le, Ly Thi Huong Luu, et al.
Publicado: (2023)

Computational Characterization of the Binding Properties of the HIV1-Neutralizing Antibody PG16 and Design of PG16-Derived CDRH3 Peptides
por: Deubler, Manuel, et al.
Publicado: (2023)

Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors
por: Alkhashrom, Sewar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tbposqkl61aim53hvbfbv548ls